Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 171-180 of 2932 for cancer

Edit search filters
  1. Low-grade UTUC Treated With Nadofaragene Firadenovec Administered To Renal Pelvis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. The Road to Wellness after Breast Cancer

    Rochester, MN

  3. RLP

    Albert Lea, MN, Mankato, MN, Rochester, MN

  4. Bemarituzumab Plus Chemotherapy And Nivolumab Versus Chemotherapy And Nivolumab Alone

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

    Jacksonville, FL

  6. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Study Of RP-3500 With Niraparib Or Olaparib In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. RP2/RP3 In Combination With Atezolizumab And Bevacizumab For The Treatment Of Patients With CRC

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Safety And Toxicity Study Of Intravesical Instillation Of TARA-002 In Adults With High-grade, Non-muscle Invasive Bladder Cancer

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer